Pfizer and BioNTech Announce Covid-19 Vaccine is Safe for Children
Young Pfizer Inc. and partner BioNTech SE announced that their Covid-19 vaccine was safe for kis aged 5-11. This announcement comes afterlate-stage research in children aged 5 to 11 years old
By
Published - Sep 20, 2021, 07:59 PM ET
Last Updated - Jun 05, 2024, 02:06 AM EDT
By Ishika Dangayach, 2:10 PM ET
Young Pfizer Inc. and partner BioNTech SE announced that their Covid-19 vaccine was safe for kis aged 5-11. This announcement comes afterlate-stage research in children aged 5 to 11 years old.
According to the businesses, the two-dose injection was shown to be safe and well-tolerated by the youngsters in the trial. The vaccination produced antibody levels comparable to those of younger adults, meeting the study's success criteria.
The data, which covered almost 2,200 children, will be submitted to the Food and Drug Administration and other health officials and it would seek emergency use authorization in the U.S. as soon as possible, according to the firms.
